| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |